Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$686M |
| 2 |
Merck
MRK
|
+$536M |
| 3 |
GoDaddy
GDDY
|
+$330M |
| 4 |
CSX Corp
CSX
|
+$227M |
| 5 |
Aramark
ARMK
|
+$217M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$372M |
| 2 |
DexCom
DXCM
|
+$339M |
| 3 |
Broadcom
AVGO
|
+$321M |
| 4 |
Adobe
ADBE
|
+$280M |
| 5 |
Meta Platforms (Facebook)
META
|
+$273M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 24.38% |
| 2 | Healthcare | 16.14% |
| 3 | Financials | 13.58% |
| 4 | Industrials | 12.86% |
| 5 | Consumer Discretionary | 11.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Hawaiian Electric Industries
HE
$2.28B
| $3.56M | ﹤0.01% |
100,000
-14,500
| -13% | -$510K |
|
1077
Huntsman Corp
HUN
$2.06B
| $3.54M | ﹤0.01% |
130,000
-73,000
| -36% | -$2.22M |
|
1078
Omega Healthcare
OHI
$15.3B
| $3.54M | ﹤0.01% |
108,032
+60,152
| +126% | +$1.91M |
|
|
B
1079
Barrick Mining
B
$62.6B
| $3.49M | ﹤0.01% |
315,269
+6,452
| +2% | +$71.8K |
|
1080
Molina Healthcare
MOH
$10.4B
| $3.48M | ﹤0.01% |
+23,400
| New | +$2.99M |
|
1081
Vanguard Mid-Cap ETF
VO
$107B
| $3.46M | ﹤0.01% |
84,316
+27,096
| +47% | +$1.11M |
|
|
SKX
1082
DELISTED
Skechers
SKX
| $3.45M | ﹤0.01% |
123,599
+35,952
| +41% | +$1.04M |
|
1083
Thomson Reuters
TRI
$42.7B
| $3.43M | ﹤0.01% |
64,740
-991
| -2% | -$49.6K |
|
1084
Fortis
FTS
$29.7B
| $3.39M | ﹤0.01% |
104,599
+3,043
| +3% | +$99K |
|
1085
Veeva Systems
VEEV
$31.6B
| $3.35M | ﹤0.01% |
30,746
-4,650
| -13% | -$422K |
|
1086
OGE Energy
OGE
$10.2B
| $3.34M | ﹤0.01% |
91,916
+59,577
| +184% | +$2.17M |
|
1087
CarMax
KMX
$8.29B
| $3.33M | ﹤0.01% |
44,635
+1,739
| +4% | +$133K |
|
|
JNPR
1088
DELISTED
Juniper Networks
JNPR
| $3.32M | ﹤0.01% |
110,903
+14,982
| +16% | +$419K |
|
|
LSXMK
1089
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
| $3.29M | ﹤0.01% |
99,574
+27,017
| +37% | +$959K |
|
1090
Martin Marietta Materials
MLM
$34.3B
| $3.24M | ﹤0.01% |
17,816
+63
| +0.4% | +$13K |
|
1091
Vanguard Industrials ETF
VIS
$8.26B
| $3.21M | ﹤0.01% |
21,699
+774
| +4% | +$112K |
|
1092
Vodafone
VOD
$36.4B
| $3.19M | ﹤0.01% |
146,897
+40,408
| +38% | +$939K |
|
1093
Catheter Precision
VTAK
$1.05M
| $3.19M | ﹤0.01% |
+1
| New | +$4.54M |
|
1094
EQT Corp
EQT
$32.5B
| $3.18M | ﹤0.01% |
132,167
+1,086
| +0.8% | +$30K |
|
1095
Qiagen
QGEN
$8.47B
| $3.17M | ﹤0.01% |
78,857
+24,893
| +46% | +$995K |
|
1096
Polaris
PII
$4.25B
| $3.11M | ﹤0.01% |
30,854
-11,300
| -27% | -$1.26M |
|
1097
Vanguard Value ETF
VTV
$189B
| $3.09M | ﹤0.01% |
27,948
+9,318
| +50% | +$1.02M |
|
1098
Incyte
INCY
$23.7B
| $3.09M | ﹤0.01% |
44,672
-6,977
| -14% | -$479K |
|
1099
Starwood Property Trust
STWD
$6.15B
| $3.06M | ﹤0.01% |
142,200
+36,630
| +35% | +$811K |
|
1100
Teva Pharmaceuticals
TEVA
$36.2B
| $3.05M | ﹤0.01% |
141,421
+14,500
| +11% | +$337K |
|
Similar funds
Janus Henderson Group's Q3 2018 Portfolio in Review
As of Q3 2018, Janus Henderson Group held 1,505 positions worth $187B, up 6.7% from $175B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Janus Henderson Group's Q3 2018 filing shows 118 new, 660 increased, 620 reduced and 63 closed positions. Its largest new stake was Elanco Animal Health: 1,976,916 shares worth $69M. The largest sale was Biogen, an estimated $372M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
- Janus Henderson Group's largest Q3 2018 buy was Elanco Animal Health: 1,976,916 shares worth $69M.
- Janus Henderson Group added most to Apple in Q3 2018, an estimated $686M increase.
- Janus Henderson Group's biggest Q3 2018 reduction was Biogen, cutting an estimated $372M.
- Janus Henderson Group fully exited Financial Engines, Inc. in Q3 2018, selling an estimated $190M.
- Janus Henderson Group's ten largest holdings make up 16% of its $187B portfolio in Q3 2018.
- Janus Henderson Group opened 118 new positions and closed 63 in Q3 2018.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $187B.
Based on Janus Henderson Group's 13F filing for Q3 2018, filed 9 Nov 2018.